You are here: Industry Insights > BioNTech

News List

When and which COVID-19 vaccines are likely to be available in Asia expresspharma
November 27, 2020
Many Asian countries do not expect to receive big amounts initially, and below are estimated distribution timelines, supply deals announced so far and clinical trials under way in the region.
Pfizer, BioNTech Submit EUA Request for COVID-19 Vaccine americanpharmaceuticalreview
November 24, 2020
Pfizer and BioNTech announced they will submit a request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of their mRNA vaccine candidate, BNT162b2 against SARS-CoV-2, which will potentially enable use of the vaccine ..
Pfizer-BioNTech COVID-19 vaccine may create set of firsts for pharma sector: GlobalData expresspharma
November 23, 2020
In modern history, no vaccine has ever been considered as essential to restoring normality to our way of life as these first mRNA vaccines, says analyst.
Britain may approve COVID-19 vaccine from Pfizer-BioNTech this week, reports Telegraph expresspharma
November 23, 2020
Britain could give regulatory approval to Pfizer-BioNTech’s COVID-19 vaccine this week, even before the US authorises it, the Telegraph news site reported.
Pfizer, BioNTech’s final Covid-19 vaccine study shows 95% efficacy pharmaceutical-technology
November 19, 2020
Pfizer and BioNTech have concluded the Phase III study of their mRNA-based Covid-19 vaccine candidate, BNT162b2, which showed 95% efficacy rate and met all primary efficacy endpoints.
EU secures 300 million doses of BioNTech, Pfizer’s COVID-19 vaccine pharmatimes
November 16, 2020
The European Commission has secured a supply deal with BioNTech and Pfizer for 300 million doses of their COVID-19 vaccine candidate.
Israel to enter into a deal with Pfizer for COVID-19 vaccine expresspharma
November 16, 2020
The supply would begin in January 2021, with the remainder arriving throughout the course of 2021: Israel’s Health Minister.
European Commission approves contract with BioNTech-Pfizer alliance worldpharmanews
November 12, 2020
Yesterday, the European Commission approved a fourth contract with pharmaceutical companies BioNTech and Pfizer, which provides for the initial purchase of 200 million doses on behalf of all EU Member States, plus an option to request up to a further ...
Pfizer, BioNTech to Supply 200M Doses of BNT162b2 to EU contractpharma
November 12, 2020
Deliveries are anticipated to start by the end of 2020, subject to clinical success and regulatory authorization.
Pfizer, BioNTech Announce COVID-19 Vaccine Demonstrates Efficacy in Phase 3 Analysis americanpharmaceuticalreview
November 11, 2020
Pfizer and BioNTech announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection, based on the first interim efficacy ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page